Kinetic interactions between 4-methylpyrazole and ethanol in healthy humans

D. Jacobsen, C Simon Sebastian, D. F. Dies, R. L. Breau, E. G. Spann, S. K. Barron, K. E. McMartin

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

4-Methylpyrazole (4-MP), a potent inhibitor of alcohol dehydrogenase activity, is a candidate to replace ethanol as the antidote for methanol and ethylene glycol intoxications, because it has a longer duration of action and apparently fewer adverse effects. To study a probable mutual inhibitory effect between ethanol and 4-MP on their elimination, two studies were performed in healthy human volunteers using double-blind crossover designs. In study A, 4-MP in the presumed therapeutic dose range of 10 to 20 mg/kg caused a 40% reduction in the rate of elimination of ethanol in 12 subjects given 0.5 to 0.7 g/kg of ethanol. These data suggest that such doses of 4-MP inhibit alcohol dehydrogenase activity in humans in vivo and would be effective at blocking methanol or ethylene glycol metabolism. In study B, ethanol (0.6 g/kg followed by 0.2 g/kg twice) significantly decreased the rate of elimination of 4-MP (5 mg/kg, given intravenously to four subjects). These moderate doses of ethanol also inhibited the rate of urinary excretion of 4-carboxypyrazole, the primary metabolite of 4-MP in humans. Data suggest that ethanol inhibits 4-MP metabolism, thereby increasing the duration of therapeutic blood levels of 4-MP in the body. This mutual interaction may have clinical implications, because most self-poisoned patients have also ingested ethanol. Theoretically, methanol and ethylene glycol might also show such interactions with 4-MP.

Original languageEnglish (US)
Pages (from-to)804-809
Number of pages6
JournalAlcoholism: Clinical and Experimental Research
Volume20
Issue number5
DOIs
StatePublished - Jan 1 1996
Externally publishedYes

Fingerprint

Ethanol
Kinetics
Ethylene Glycol
Methanol
Alcohol Dehydrogenase
Metabolism
fomepizole
Antidotes
Metabolites
Human Activities
Cross-Over Studies
Healthy Volunteers
Blood
Therapeutics

Keywords

  • Alcohol Dehydrogenase
  • Cytochrome P-450
  • Drug Metabolism
  • Ethylene Glycol Poisoning
  • Methanol Poisoning

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Toxicology
  • Psychiatry and Mental health

Cite this

Kinetic interactions between 4-methylpyrazole and ethanol in healthy humans. / Jacobsen, D.; Sebastian, C Simon; Dies, D. F.; Breau, R. L.; Spann, E. G.; Barron, S. K.; McMartin, K. E.

In: Alcoholism: Clinical and Experimental Research, Vol. 20, No. 5, 01.01.1996, p. 804-809.

Research output: Contribution to journalArticle

Jacobsen, D. ; Sebastian, C Simon ; Dies, D. F. ; Breau, R. L. ; Spann, E. G. ; Barron, S. K. ; McMartin, K. E. / Kinetic interactions between 4-methylpyrazole and ethanol in healthy humans. In: Alcoholism: Clinical and Experimental Research. 1996 ; Vol. 20, No. 5. pp. 804-809.
@article{61fd6f9f04324bea8e49c98dac317de1,
title = "Kinetic interactions between 4-methylpyrazole and ethanol in healthy humans",
abstract = "4-Methylpyrazole (4-MP), a potent inhibitor of alcohol dehydrogenase activity, is a candidate to replace ethanol as the antidote for methanol and ethylene glycol intoxications, because it has a longer duration of action and apparently fewer adverse effects. To study a probable mutual inhibitory effect between ethanol and 4-MP on their elimination, two studies were performed in healthy human volunteers using double-blind crossover designs. In study A, 4-MP in the presumed therapeutic dose range of 10 to 20 mg/kg caused a 40{\%} reduction in the rate of elimination of ethanol in 12 subjects given 0.5 to 0.7 g/kg of ethanol. These data suggest that such doses of 4-MP inhibit alcohol dehydrogenase activity in humans in vivo and would be effective at blocking methanol or ethylene glycol metabolism. In study B, ethanol (0.6 g/kg followed by 0.2 g/kg twice) significantly decreased the rate of elimination of 4-MP (5 mg/kg, given intravenously to four subjects). These moderate doses of ethanol also inhibited the rate of urinary excretion of 4-carboxypyrazole, the primary metabolite of 4-MP in humans. Data suggest that ethanol inhibits 4-MP metabolism, thereby increasing the duration of therapeutic blood levels of 4-MP in the body. This mutual interaction may have clinical implications, because most self-poisoned patients have also ingested ethanol. Theoretically, methanol and ethylene glycol might also show such interactions with 4-MP.",
keywords = "Alcohol Dehydrogenase, Cytochrome P-450, Drug Metabolism, Ethylene Glycol Poisoning, Methanol Poisoning",
author = "D. Jacobsen and Sebastian, {C Simon} and Dies, {D. F.} and Breau, {R. L.} and Spann, {E. G.} and Barron, {S. K.} and McMartin, {K. E.}",
year = "1996",
month = "1",
day = "1",
doi = "10.1111/j.1530-0277.1996.tb05255.x",
language = "English (US)",
volume = "20",
pages = "804--809",
journal = "Alcoholism: Clinical and Experimental Research",
issn = "0145-6008",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Kinetic interactions between 4-methylpyrazole and ethanol in healthy humans

AU - Jacobsen, D.

AU - Sebastian, C Simon

AU - Dies, D. F.

AU - Breau, R. L.

AU - Spann, E. G.

AU - Barron, S. K.

AU - McMartin, K. E.

PY - 1996/1/1

Y1 - 1996/1/1

N2 - 4-Methylpyrazole (4-MP), a potent inhibitor of alcohol dehydrogenase activity, is a candidate to replace ethanol as the antidote for methanol and ethylene glycol intoxications, because it has a longer duration of action and apparently fewer adverse effects. To study a probable mutual inhibitory effect between ethanol and 4-MP on their elimination, two studies were performed in healthy human volunteers using double-blind crossover designs. In study A, 4-MP in the presumed therapeutic dose range of 10 to 20 mg/kg caused a 40% reduction in the rate of elimination of ethanol in 12 subjects given 0.5 to 0.7 g/kg of ethanol. These data suggest that such doses of 4-MP inhibit alcohol dehydrogenase activity in humans in vivo and would be effective at blocking methanol or ethylene glycol metabolism. In study B, ethanol (0.6 g/kg followed by 0.2 g/kg twice) significantly decreased the rate of elimination of 4-MP (5 mg/kg, given intravenously to four subjects). These moderate doses of ethanol also inhibited the rate of urinary excretion of 4-carboxypyrazole, the primary metabolite of 4-MP in humans. Data suggest that ethanol inhibits 4-MP metabolism, thereby increasing the duration of therapeutic blood levels of 4-MP in the body. This mutual interaction may have clinical implications, because most self-poisoned patients have also ingested ethanol. Theoretically, methanol and ethylene glycol might also show such interactions with 4-MP.

AB - 4-Methylpyrazole (4-MP), a potent inhibitor of alcohol dehydrogenase activity, is a candidate to replace ethanol as the antidote for methanol and ethylene glycol intoxications, because it has a longer duration of action and apparently fewer adverse effects. To study a probable mutual inhibitory effect between ethanol and 4-MP on their elimination, two studies were performed in healthy human volunteers using double-blind crossover designs. In study A, 4-MP in the presumed therapeutic dose range of 10 to 20 mg/kg caused a 40% reduction in the rate of elimination of ethanol in 12 subjects given 0.5 to 0.7 g/kg of ethanol. These data suggest that such doses of 4-MP inhibit alcohol dehydrogenase activity in humans in vivo and would be effective at blocking methanol or ethylene glycol metabolism. In study B, ethanol (0.6 g/kg followed by 0.2 g/kg twice) significantly decreased the rate of elimination of 4-MP (5 mg/kg, given intravenously to four subjects). These moderate doses of ethanol also inhibited the rate of urinary excretion of 4-carboxypyrazole, the primary metabolite of 4-MP in humans. Data suggest that ethanol inhibits 4-MP metabolism, thereby increasing the duration of therapeutic blood levels of 4-MP in the body. This mutual interaction may have clinical implications, because most self-poisoned patients have also ingested ethanol. Theoretically, methanol and ethylene glycol might also show such interactions with 4-MP.

KW - Alcohol Dehydrogenase

KW - Cytochrome P-450

KW - Drug Metabolism

KW - Ethylene Glycol Poisoning

KW - Methanol Poisoning

UR - http://www.scopus.com/inward/record.url?scp=0029812026&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029812026&partnerID=8YFLogxK

U2 - 10.1111/j.1530-0277.1996.tb05255.x

DO - 10.1111/j.1530-0277.1996.tb05255.x

M3 - Article

C2 - 8865952

AN - SCOPUS:0029812026

VL - 20

SP - 804

EP - 809

JO - Alcoholism: Clinical and Experimental Research

JF - Alcoholism: Clinical and Experimental Research

SN - 0145-6008

IS - 5

ER -